October 2023

Oncology leaders and pharma representatives discuss collaboration best practices.

The fast pace of information can make it difficult to efficiently apply data to care.

Integrating immunotherapies will continue to improve patient outcomes and quality of life.

A panel hosted by HOPA, ACCC, and AVAHO discusses strategies to ensure patient access to treatment.

This patient population has had low survival rates with available treatments.

Mental health treatment may be necessary when SAEs occur.

AI systems can detect minute anomalies often missed by the human eye, reducing false negatives.

TRPV1 inhibition overcomes cisplatin resistance by blocking autophagy-mediated hyperactivation of the EGFR signaling pathway.

Collaboration between AI-based platforms and health care organizations offers promising results.

A single-center experience at a tertiary medical center precision medicine clinic provides insight.

Ongoing studies utilizing large-scale health databases that incorporate environmental, lifestyle, biological, and phenotypic data may provide insight that leads to better cancer prevention and treatment.

Artificial intelligence has helped ensure a data-driven methodology for evaluating eligibility criteria for clinical trials, facilitating more inclusive trial design.